An official website of the United States government
Home
Name
Temsirolimus
Alternate Names
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--antiangiogenic agent
mTOR inhibitor
NSC Number
683864
Primary Site
Histology
None
Remarks
FDA approved for renal cell carcinoma of the kidney 2007; in trials for breast, colorectal, lung, pancreatic, prostate, sarcoma. Second generation mTOR inhibitor.
NOTE: this drug is a type of rapamycin analog/rapamycin ester and should not be confused with the drug "Rapamycin, NOS" which is used to treat GVHD (graft versus host disease) for transplant patients. Careful review of the medical record should be done to dtermine which drug was given and for what reason.
NOTE: this drug is a type of rapamycin analog/rapamycin ester and should not be confused with the drug "Rapamycin, NOS" which is used to treat GVHD (graft versus host disease) for transplant patients. Careful review of the medical record should be done to dtermine which drug was given and for what reason.
Coding
This drug should be coded
